SCHEMBL21363944

SCHEMBL21363944

C=CC(=O)Nc1cc(Nc2ncc(N3CCOCC3)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCN(C)CC1

nearest known ligand 0.78

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 17/20 0.78
▸ ALK Q9UM73 8/20 0.78
▸ EML4 Q9HC35 3/20 0.55
▸ ROS1 P08922 2/20 0.55
▸ ERBB2 P04626 1/20 0.55
▸ INSR P06213 1/20 0.55
▸ FER P16591 1/20 0.55
▸ LTK P29376 1/20 0.55
▸ BLK P51451 1/20 0.55
▸ PTK2 Q05397 1/20 0.55
▸ BTK Q06187 1/20 0.55
▸ TNK2 Q07912 1/20 0.55
▸ ERBB4 Q15303 1/20 0.55
▸ SLK Q9H2G2 1/20 0.55
▸ IGF1R P08069 2/20 0.54
▸ KCNH2 Q12809 2/20 0.54
▸ MET P08581 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21358354 0.96 EGFR (0.72) EGFRALKEML4ROS1ERBB2
SCHEMBL19027384 0.91 ALK (0.82) EGFRALKEML4ROS1ERBB2
SCHEMBL19027794 0.90 ALK (0.95) EGFRALKEML4ROS1ERBB2
SCHEMBL19027749 0.88 ALK (1.00) EGFRALKEML4ROS1ERBB2
SCHEMBL21363943 0.87 ALK (0.59) EGFRALKEML4ROS1ERBB2
SCHEMBL19027406 0.85 ALK (0.73) EGFRALKEML4ROS1ERBB2
SCHEMBL19027412 0.85 ALK (0.85) EGFRALKEML4ROS1ERBB2
SCHEMBL21364088 0.84 EGFR (0.63) EGFRALKIGF1RKCNH2
SCHEMBL19027947 0.84 ALK (0.84) EGFRALKEML4ROS1ERBB2
SCHEMBL19027405 0.84 ALK (0.89) EGFRALKEML4ROS1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019177375-A1 2, 4, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 포로노이바이오 주식회사 2019-09-19 — — WO disclosed
Send feedback